<scp>IRANCANSURV</scp> : A comprehensive analysis of childhood cancer survival in Iran

We aimed to assess the 5-year survival probability of childhood cancer in Iran, utilizing data from eight population-based cancer registries across the country. The study employed data from 1809 childhood cancer patients aged 0-14 years, diagnosed between 2014 and 2016. Patients underwent active and passive follow-up procedures, and cases with uncertain vital status were excluded. We used the relative survival method to estimate age-standardized net survival probability for childhood cancer in Iran. The 5-year net survival for leukemia was 67.85% (95% confidence interval [CI] = 64.57, 70.90), while for central nervous system (CNS) cancers, it was 48.63% (95% CI = 43.21, 53.82). An analysis of regional disparities revealed a significant discrepancy of 14.56% in the 5-year survival of childhood leukemia, from 56.96 % in West Azerbaijan to 71.52% in Fars province. The geographical disparity in the 5-year survival of childhood CNS cancer became more pronounced, with a staggering 57.33% difference ranging from 73.50% in Khuzestan to 16.17% in Isfahan provinces. The study highlights low childhood cancer survival rates in Iran and calls for a robust surveillance system, public awareness campaigns, implementing national clinical practice guidelines, and financial support from government and NGOs to improve patient outcomes.

Authors

Institutions

Publication Details

Journal
International Journal of Cancer
Published
2025-09-01
DOI
https://doi.org/10.1002/ijc.70100
Primary Topic
Childhood Cancer Survivors' Quality of Life
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

IRANCANSURV : A comprehensive analysis of childhood cancer survival in Iran

Fereshte Lotfi, Arash Golpazir, Roya Dolatkhah, Majid Yaghoobi‐Ashrafi et al.
International Journal of Cancer
Childhood Cancer Survivors' Quality of Life
article

IRANCANSURV : A comprehensive analysis of childhood cancer survival in Iran

Fereshte Lotfi, Arash Golpazir, Roya Dolatkhah, Majid Yaghoobi‐Ashrafi, Allison Domingues, Habibollah Pirnejad, Zahra Ravankhah, Sepideh Abdi, Azin Nahvijou, Saeed Nemati, Kazem Zendehdel, Saba Alvand, Maria Cheraghi, Abbas Rezaeianzadeh, Elham Mohebbi, Azam Bazarafshan, Elnaz Saeedi, Nastaran Niami
article en

Abstract

We aimed to assess the 5-year survival probability of childhood cancer in Iran, utilizing data from eight population-based cancer registries across the country. The study employed data from 1809 childhood cancer patients aged 0-14 years, diagnosed between 2014 and 2016. Patients underwent active and passive follow-up procedures, and cases with uncertain vital status were excluded. We used the relative survival method to estimate age-standardized net survival probability for childhood cancer in Iran. The 5-year net survival for leukemia was 67.85% (95% confidence interval [CI] = 64.57, 70.90), while for central nervous system (CNS) cancers, it was 48.63% (95% CI = 43.21, 53.82). An analysis of regional disparities revealed a significant discrepancy of 14.56% in the 5-year survival of childhood leukemia, from 56.96 % in West Azerbaijan to 71.52% in Fars province. The geographical disparity in the 5-year survival of childhood CNS cancer became more pronounced, with a staggering 57.33% difference ranging from 73.50% in Khuzestan to 16.17% in Isfahan provinces. The study highlights low childhood cancer survival rates in Iran and calls for a robust surveillance system, public awareness campaigns, implementing national clinical practice guidelines, and financial support from government and NGOs to improve patient outcomes.

International Journal of CancerVol. 158(4)
Isfahan University of Medical Sciences (IR), Ahvaz Jundishapur University of Medical Sciences (IR), Beth Israel Deaconess Medical Center (US), Harvard University (US), Iran University of Medical Sciences (IR), Tabriz University of Medical Sciences (IR), Georgetown University (US), Shiraz University of Medical Sciences (IR), Kerman University of Medical Sciences (IR), Nuffield Orthopaedic Centre (GB), Urmia University (IR), University of Isfahan (IR), Kermanshah University of Medical Sciences (IR), Shariati Hospital (IR), Motamed Cancer Institute (IR), Centre international de recherche sur le cancer (FR), Urmia University of Medical Sciences (IR), Tehran University of Medical Sciences (IR), Mazandaran University of Medical Sciences (IR), University of Bologna (IT)
Openalex Percentile: Top 68%
Childhood Cancer Survivors' Quality of Life
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.